INO

1.43

5.15% 0.07

Dopo l'orario di chiusura: 1.42 -0.01 -0.70%

Inovio Pharmaceuticals Inc (INO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.36

Aprire:

$1.35

Volume 24 ore:

2.89M

Relative Volume:

0.91

Capitalizzazione di mercato:

$147.86M

Reddito:

$65,300

Utile/perdita netta:

$-84.93M

Rapporto P/E:

-0.8372

EPS:

-1.708

Flusso di cassa netto:

$-83.57M

1 W Prestazione:

+10.85%

1M Prestazione:

+115.65%

6M Prestazione:

-17.34%

1 anno Prestazione:

-48.00%

Intervallo 1D:

$1.35

$1.43

Intervallo di 1 settimana:

$1.22

$1.44

Portata 52W:

$0.5632

$2.9789

Inovio Pharmaceuticals Inc Stock (INO) Company Profile

Nome

Inovio Pharmaceuticals Inc

Settore

Healthcare (1074)

Industria

Biotechnology (600)

Telefono

(858) 410-3134

Indirizzo

660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA

Dipendente

112

Cinguettio

@inoviopharma

Prossima data di guadagno

2026-08-12

Ultimi documenti SEC

INO's Discussions on Twitter

Compare INO vs VRTX, REGN, ARGX, MRNA, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
INO Inovio Pharmaceuticals Inc	1.43	125.11M	65,300	-84.93M	-83.57M	-1.708
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-09	Iniziato	Piper Sandler	Overweight
2024-05-14	Iniziato	Stephens	Overweight
2024-01-25	Aggiornamento	Oppenheimer	Perform → Outperform
2022-11-09	Downgrade	Maxim Group	Buy → Hold
2022-11-01	Downgrade	BofA Securities	Neutral → Underperform
2022-07-19	Ripresa	RBC Capital Mkts	Sector Perform
2022-05-11	Downgrade	Oppenheimer	Outperform → Perform
2022-01-21	Aggiornamento	BofA Securities	Underperform → Neutral
2021-12-29	Ripresa	Jefferies	Hold
2021-09-10	Downgrade	BofA Securities	Neutral → Underperform
2021-06-24	Iniziato	Jefferies	Hold
2021-03-23	Iniziato	BofA Securities	Neutral
2021-02-12	Iniziato	Oppenheimer	Outperform
2020-11-17	Downgrade	ROTH Capital	Neutral → Sell
2020-11-10	Aggiornamento	ROTH Capital	Sell → Neutral
2020-09-28	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2020-09-28	Aggiornamento	Maxim Group	Hold → Buy
2020-07-01	Downgrade	Maxim Group	Buy → Hold
2020-07-01	Downgrade	ROTH Capital	Neutral → Sell
2020-06-29	Downgrade	H.C. Wainwright	Buy → Neutral
2020-06-26	Downgrade	Stifel	Buy → Hold
2020-05-21	Iniziato	The Benchmark Company	Buy
2020-04-30	Downgrade	ROTH Capital	Buy → Neutral
2020-03-13	Downgrade	Piper Sandler	Overweight → Neutral
2020-03-13	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2019-12-19	Iniziato	ROTH Capital	Buy
2018-02-15	Reiterato	Maxim Group	Buy
2017-10-18	Iniziato	RBC Capital Mkts	Outperform
2017-09-06	Iniziato	Citigroup	Buy
2017-06-08	Aggiornamento	Piper Jaffray	Neutral → Overweight
2017-05-24	Reiterato	Maxim Group	Buy
2017-03-16	Aggiornamento	Maxim Group	Hold → Buy
2017-03-16	Downgrade	Piper Jaffray	Overweight → Neutral

Mostra tutto

Inovio Pharmaceuticals Inc Borsa (INO) Ultime notizie

Aug 21, 2026

Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

Aug 21, 2026

Aug 20, 2026

Inovio (INO) Results Versus Estimates: Profit Per Share Clears Its Benchmark in Latest Trading; Market Response: The Stock Ends Down 6.92%Pre-Earnings Setup - Vinanet

Aug 20, 2026

Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Aug 20, 2026

Inovio Pharmaceuticals Company Profile & Introduction - Moomoo

Aug 20, 2026

INO, MRNA, NVAX, EBS Jump Overnight: Trump Promises Full Hantavirus Report As Deadly Outbreak Sparks Vaccine Rally - Stocktwits

Aug 20, 2026

Aug 19, 2026

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Aug 19, 2026

Inovio (INO) Earnings Check: The Available Earnings Metric Delivers a Beat at the Close; Post-Report Move: The Stock Ends Up 4.35% in the Latest ReadingFinancial Data - Vinanet

Aug 19, 2026

Aug 17, 2026

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to "Hold" at Wall Street Zen - MarketBeat

Aug 15, 2026

Aug 14, 2026

INOVIO Sets Aug. 12 Earnings Update With Business Review - MyChesCo

Aug 14, 2026

Inovio Pharmaceuticals Highlights FDA Inspection Completion and INO-3107 Regulatory Progress in Q2 2026 Earnings CallDividend Earnings Report - Vinanet

Aug 14, 2026

HC Wainwright Issues Negative Estimate for INO Earnings - MarketBeat

Aug 14, 2026

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to Strong-Buy at Zacks Research - MarketBeat

Aug 14, 2026

Aug 13, 2026

INO Upgraded by Jefferies -- Price Target Raised to $3.00 - GuruFocus

Aug 13, 2026

Piper Sandler Maintains Inovio Pharmaceuticals(INO.US) With Buy Rating, Maintains Target Price $4 - Moomoo

Aug 13, 2026

Jefferies Maintains Inovio Pharmaceuticals(INO.US) With Buy Rating, Raises Target Price to $3 - Moomoo

Aug 13, 2026

H.C. Wainwright reiterates Neutral on Inovio stock, $2.50 target - Investing.com

Aug 13, 2026

H.C. Wainwright reiterates Neutral on Inovio stock, $2.50 target By Investing.com - Investing.com Canada

Aug 13, 2026

Jefferies upgrades Inovio stock rating on FDA review progress - Investing.com

Aug 13, 2026

Inovio Q2 2026 slides: INO-3107 on track for Oct FDA decision - Investing.com Nigeria

Aug 13, 2026

Jefferies upgrades Inovio stock rating on FDA review progress By Investing.com - Investing.com Canada

Aug 13, 2026

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Aug 13, 2026

Inovio Pharmaceuticals (NASDAQ:INO): What Does the Latest Update Mean for Regulatory Progress? - Kalkine Media

Aug 13, 2026

H.C. Wainwright Maintains Inovio Pharmaceuticals(INO.US) With Hold Rating, Maintains Target Price $2.5 - Moomoo

Aug 13, 2026